Market Blog » The Arora Report Stock Market News

TAKING PROFITS ON XENOPORT (XNPT)

May 22, 2011

Subscribers to the ZYX Short Sell Change Alert took profits on Xenoport (XNPT) on May 5,2011 at $7.35. Following was the entry on the Real Time Feed: Most of our subscribers have already realized over 20% profit on XNPT over a very short time. After earnings report, the stock is now down to $7.35. Those still holding a partial position may consider taking profits right here and completely exiting the position. The risk of continuing to hold the position outweighs the potential reward. Those not in the position should not enter. Inadvertently, this signal on Xenoport

TAKING PARTIAL PROFITS ON ACORDA THERAPEUTICS (ACOR)

May 22, 2011

Subscribers to ZYX Short Sell Change Alert took partial profits on Acorda Therapeutics (ACOR)at $30.20 on Friday. We are holding partial position for the prices to hit our target zone. This target zone was provided to the subscribers of ZYX Short Sell Change Alert at the time of the trade entry on Acorda Therapeutics.

LINKEDIN (LNKD): LOW RISK WAYS TO MAKE MONEY

May 20, 2011

LinkedIn (LNKD) frenzy continues. Fundamentals do not justify buying LinkedIn at this level. LinkedIn is no Google (GOOG). Options will start trading Thursday and stock should become available for shorting after that. An analysis of the historical data of similar situations shows that shorting this stock in the near term will be a disaster. There are low risk ways to make money from LinkedIn. Here are the excerpts from my article on Seeking Alpha: LinkedIn: Overvalued, But a Dangerous Short LinkedIn (LNKD) went public Thursday, setting a frenzy on Wall Street. It was

TAKING PARTIAL PROFITS ON LIMITED BRANDS (LTD)

May 20, 2011

We are taking partial profits on LTD right here at $39.22. We will leave the rest to hit our target zone.

ACORDA THERAPEUTICS (ACOR) UP MOVE IS AN OPPORTUNITY

May 20, 2011

Acorda Therapeutics (ACOR) is up due to the positive opinion on Marketing Authorization Application for its MS drug Ampyra in Europe. This approval for Acorda Therapeutics was expected. The big move in Acorda is unwarranted. We are short selling in the strength now with an average price $32.98 and will add if the stock goes higher. As a full disclosure, this alert was earlier published in ZYX Short Sell Change Alert — Real Time Feed. For stops and targets please see ZYX Short Sell Change Alert.

LIMITED BRANDS (LTD): TIME TO TAKE PROFITS

May 19, 2011

We are taking partial profits on Limited Brands (LTD) right here at $40.87. Please see the prior entry for details of the entry.

LIMITED BRANDS (LTD) BOUNCE IS AN OPPORTUNITY TO SELL

May 19, 2011

Limited Brands (LTD) reported earnings after the close. The earnings were below the whisper number. The projections of Limited Brands was less than the published consensus and quite a bit below the whisper numbers. The growth of Limited Brands is clearly slowing. Bounce in the stock is an opportunity to sell or short sell. We are now short from an average price of $43.09. ZYX Short Sell Change Alert — Real Time Feed has been providing actionable signals on this stock. For details of our trades please see ZYX Short Sell Change Alert.

REASON FOR LONGTOP FINANCIAL (LFT) HALT

May 18, 2011

Longtop financial (LFT) was scheduled to report earnings on May 23rd as we have previously pointed out. Longtop Financial has announced that it will not be reporting earnings on May 23rd and has not yet provided another date. It is difficult to interpret this information. Is there a serious problem? Is this simply a case of accountants getting delayed for some innocuous reason? We will keep you informed about Longtop Financial as we learn more.